Education
About Us
Working with TipRanks
Follow Us
Pulse Biosciences (PLSE)
NASDAQ:PLSE
Total Valuation
Pulse Biosciences has a market cap or net worth of $1.05B. The enterprise value is $917.09M.
Market Cap$1.05B
Enterprise Value$917.09M
Share Statistics
Pulse Biosciences has 67,278,340 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding67,278,340
Owned by Insiders73.85%
Owned by Institutions0.64%
Financial Efficiency
Pulse Biosciences’s return on equity (ROE) is -0.47 and return on invested capital (ROIC) is -43.92%.
Return on Equity (ROE)-0.47
Return on Assets (ROA)-0.40
Return on Invested Capital (ROIC)-43.92%
Return on Capital Employed (ROCE)-0.44
Revenue Per Employee0.00
Profits Per Employee-714.47K
Employee Count75
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Pulse Biosciences is ―. Pulse Biosciences’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value8.85
Price to FCF―
Price to Operating Cash Flow-26.73
PEG Ratio―
Income Statement
In the last 12 months, Pulse Biosciences had revenue of 0.00 and earned -53.59M in profits. Earnings per share was -0.92.
Revenue0.00
Gross Profit-1.18M
Operating Income-54.36M
Pretax Income-53.59M
Net Income-53.59M
EBITDA-52.41M
Earnings Per Share (EPS)-0.92
Cash Flow
In the last 12 months, operating cash flow was -44.50M and capital expenditures -239.00K, giving a free cash flow of -44.73M billion.
Operating Cash Flow-44.50M
Free Cash Flow-44.73M
Free Cash Flow per Share-0.66
Dividends & Yields
Pulse Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.62
52-Week Price Change-9.12%
50-Day Moving Average15.52
200-Day Moving Average17.27
Relative Strength Index (RSI)47.62
Average Volume (3m)154.25K
Important Dates
Pulse Biosciences upcoming earnings date is Nov 17, 2025, After Close (Confirmed).
Last Earnings DateAug 12, 2025
Next Earnings DateNov 17, 2025
Ex-Dividend Date―
Financial Position
Pulse Biosciences as a current ratio of 11.88, with Debt / Equity ratio of 7.89%
Current Ratio11.88
Quick Ratio11.88
Debt to Market Cap0.00
Net Debt to EBITDA2.08
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Pulse Biosciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Pulse Biosciences EV to EBITDA ratio is -17.32, with an EV/FCF ratio of -24.89.
EV to Sales0.00
EV to EBITDA-17.32
EV to Free Cash Flow-24.89
EV to Operating Cash Flow-24.97
Balance Sheet
Pulse Biosciences has $106.35M in cash and marketable securities with $8.24M in debt, giving a net cash position of -$98.10M billion.
Cash & Marketable Securities$106.35M
Total Debt$8.24M
Net Cash-$98.10M
Net Cash Per Share-$1.46
Tangible Book Value Per Share$1.90
Margins
Gross margin is 16.95%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin16.95%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Pulse Biosciences is $22.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$22.00
Price Target Upside41.57% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast-33.24%